Use of Ozone-Depleting Substances; Removal of Essential-Use Designation (Flunisolide, etc.); Correction
other · Food and Drug Administration · Rule · Published 2010-09-17 · 75 FR 56858
Document
Document number
2010-23195
Federal Register citation
75 FR 56858
CFR reference
21 CFR 2
Type
Rule
Action
Final rule; correction.
Category
other
Sub-agency
Food and Drug Administration
Publication date
2010-09-17
HHS docket
Docket No. FDA-2006-N-0304
Abstract
The Food and Drug Administration (FDA) is correcting a final rule that appeared in the Federal Register of April 14, 2010 (75 FR 19213). The document amended FDA's regulation on the use of ozone- depleting substances (ODSs) in self-pressurized containers to remove the essential-use designations for flunisolide, triamcinolone, metaproterenol, pirbuterol, albuterol and ipratropium in combination, cromolyn, and nedocromil used in oral pressurized metered-dose inhalers (MDIs). The document was published with an inadvertent error. This document corrects that error.